INTRODUCTION
Despite considerable advancements in elucidating pathognomonic genetic and molecular alterations, the causal mechanisms underlying initiation and progression of colorectal cancer, the third most common and deadly neoplasm in the western world, remain unknown. In the paracrine hormone hypothesis of colon cancer, 1 tumorigenesis is characterized by a state of guanylyl cyclase C (GCC) ligand insufficiency, in which expression of endogenous hormones guanylin and uroguanylin, secreted by and activating GCC receptors on intestinal epithelial cells in an autocrine and paracrine fashion, is dramatically reduced following a yet unidentified event early during transformation. [2] [3] Ligand-induced GCC activation physiologically regulates intestinal fluid and electrolyte homeostasis through intracellular accumulation of the second messenger cyclic guanosine monophosphate (cGMP) and cGMP-dependent protein kinase (PKG) phosphorylation of ion channels. 4 Activation of GCC also promotes the transition from the proliferative crypt phenotype to the differentiated colonocyte along intestinal mucosal surfaces by imposing cytostasis 5 and oxidative metabolic reprogramming, 6 effects presumably underlying GCC-mediated colorectal antitumorigenesis. 7 Thus, the GCC ligandopenia associated with neoplastic transformation may promote colorectal carcinogenesis by producing a repressed GCC and cGMP pathway devoid of tumor suppressor activities. However, the exact consequences at the molecular level of the absence of GCC activation in colon cancer cells are unclear.
A poorly investigated target for the antitumorigenic GCC pathway is the vasodilatorstimulated phosphoprotein (VASP). 8 A mammalian member of the highly conserved 4 Ena/VASP family proteins, VASP acts as a molecular scaffold to bring together growing actin filaments with regulatory proteins at the cell leading edge. 9 VASP controls cell spreading and migration by regulating the formation and stability of protrusive membrane structures driven by actin polymerization, including lamellipodia and filopodia, and the integrity of cell-matrix interactions at adhesion complexes. 9 In that context, VASP exerts a pivotal role in filopodial dynamics, reflected by its localization at the filopodial tip complex where it promotes filopodia formation and elongation by recruiting the initial nanomachinery and imposing anti-capping pressure on actin filament barbed ends. 10 Three critical domains mediates VASP/actin interactions: 9 1) the Ena/VASP homology 1 (EVH1) domain at the N-terminus, which binds to proteins with poly-proline II helix, including vinculin and zyxin; 2) the central prolin-rich region, which binds to proteins containing SH3 and WW domains and the globular (G)-actin binding profilin, and 3) the EVH2 domain at the C-terminus, which binds to both G-and filamentous (F)-actin and mediates VASP oligomerization, thereby promoting F-actin bundling and stabilization.
Importantly, VASP harbors 3 phosphorylation sites (Ser157, Ser239 and Thr278) which are targeted with different affinities by PKG, cAMP-dependent protein kinase and AMPactivated protein kinase, and modulate its localization and function.
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Phosphorylation of VASP Ser239, adjacent to the G-actin binding site in the EVH2 domain, is selectively regulated by cGMP-dependent signaling through PKG, 11 an event that disrupts VASP anti-capping and filament-bundling activities and inhibits membrane protrusion formation. 9, 14 While its engagement in migration and membrane protrusion dynamics in normal cells is well-established, a similar role for VASP Ser phosphorylation in cancer cells has not 5 emerged. However, actin cytoskeletal remodeling at dynamic membrane regions determines oncogenic behaviors, from epithelial-to-mesenchymal transition to tissue invasion and metastasis. [15] [16] In principle, PKG-mediated VASP phosphorylation could represent one of the biochemical reactions of the antitumorigenic GCC/cGMP signalome. suppressed the invasive cancer cell phenotype, with disassembly of protrusive membrane organelles (filopodia, invadopodia) and inability to promote DQ-collagen IV degradation.
Together, these observations reveal a previously unrecognized suppressor of invasive membrane protrusions and therapeutic target, VASP Ser239 phosphorylation, for colorectal cancer.
MATERIAL AND METHODS
Reagents. ST was prepared as described, GCC signaling through VASP is dysregulated in colon cancer. In the human colon, the GCC pathway is constitutively activated by the paracrine hormone guanylin, which induces cGMP-and PKG-dependent phosphorylation of specific substrates. 1, 4 Accordingly, normal colonic mucosa from patients exhibited epithelial cells with VASP Ser157 and Ser239 phosphorylation in the context of an intact guanylin-VASP signaling axis (Fig. 2a, upper panel) . However, following transformation and loss of endogenous ligand expression [2] [3] this GCC pathway becomes dysregulated (Fig. 2a, upper panel) .
While GCC and PKG exhibited mixed trends with no significant changes, expression of guanylin and all the VASP species were significantly reduced in colorectal adenocarcinomas compared to their respective normal counterparts (Fig. 2a) . Of significance, VASP phosphorylation at Ser157 and Ser239 were the most compromised signals of the GCC pathway, reflected by their downregulation in all tumors examined (Fig. 2a, middle panel) and maximal loss of expression (Fig. 2a, lower panel) . Thus, loss of VASP Ser phosphorylation in colon cancer reflects interruption of effective induction and transmission of GCC-VASP signaling, beyond the mere changes in VASP expression (Supporting Information Fig. 3 ).
VASP Ser239 phosphorylation by GCC activation inhibits cancer cell shape mediating migration and invasion. As VASP regulates membrane protrusion geometry 18 and is present at cell leading edges and invadopodia (Fig. 1a-b) , the functional consequences of ligand-dependent GCC signaling through VASP Ser phosphorylation on the membrane architecture of colon cancer cells were examined.
GCC signaling through cGMP significantly reduced the number and length of migratory (filopodia; Fig. 2b ) and invasive (invadopodia; Fig. 2c ) actin-based protrusions. . 4b) , were resistant to GCC-mediated inhibition of filopodia (Fig. 3) and invadopodia (Fig. 4) . In contrast, control cells expressing GFP or overexpressing VASP and tumor cells with the phosphomutant VASP-S157A, which harbors a point mutation at
Ser157 only and does not accept phosphorylation at that site (Supporting Information Fig.   4b ), were sensitive to suppression of filopodia ( (Fig. 5a ) and invadopodia ( Fig. 5b ) upon liganddependent GCC activation. Protrusion retraction by GCC (Fig. 5c ) reflected rapid removal of VASP from membrane projections (Fig. 5d) , with a calculated half-life of 8.11 min (Supporting Information Fig. 5 ), and VASP redistribution to inner cell compartments away from membrane tips (Fig. 5e) . However, the GFP-VASP-S239A mutant (resistant to Ser239 phosphorylation), was insensitive to GCC signaling (Fig. 5c) , and retained its localization (Fig. 5d) and distribution ( (Fig. 1c) . Strikingly, activation of GCC signaling through VASP abolished the cancer ability to degrade DQ-collagen IV, with similar magnitude to that of a general inhibitor of MMPs (Fig. 6a) , enzymes mediating tumor matrix degradation. 20 However, colon cancer cells with VASP-S239A or VASP-AA, but not VASP-S157A, did continue to proteolytically digest DQ-collagen IV following ligand-dependent GCC signaling ( Fig.   6a ), indicating that VASP Ser239 phosphorylation mediates arrest of invadopodiamediated proteolysis by the GCC pathway. Thus, VASP Ser239 phosphorylation is a unique biochemical reaction that suppresses membrane protrusions promoting tumor invasion in colorectal cancer (Fig. 6b) .
DISCUSSION
The antitumorigenic GCC signalome is deregulated during colorectal transformation reflecting loss of endogenous ligand expression. (Fig. 6b ) described herein.
Membrane protrusion extension principally reflects the balance of antagonistic forces at actin filament barbed ends imposing persistence (anti-capping proteins) or arrest (capping proteins) of actin polymerization. 10 VASP is a critical anti-capping protein that initiates and maintains dynamic membrane regions by orchestrating a cytoskeletal assembly-line promoting simultaneous F-actin elongation and bundling. 10, 22 In this way, Ena/VASP family members control migration and membrane protrusion formation underlying important physio(patho)logical processes, from wound-healing, platelet aggregation and neural development 9 to inflammation, cancer spreading and metastasis. 
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Thus, the ability of cGMP-dependent VASP phosphorylation to dismantle invadopodia in colon cancer cells (Fig. 4) offers an innovative antiinvadopodial strategy to be exploited against tumor metastasis in patients.
Tumor Since VASP Ser239 is selectively regulated by PKG-dependent phosphorylation, 9, 14 while VASP Ser157 is a more promiscuous site phosphorylated by PKG, cAMPdependent protein kinase, and protein kinase C-dependent and -independent mechanisms, 11, 29 present observations suggest a unique role of the GCC/cGMP/PKG pathway in suppressing colorectal cancer invasion through VASP Ser239. Reduced levels of VASP Ser157 phosphorylation in colon cancer (Fig. 2a) , in turn, may reflect more complex deregulation of tumor intracellular networks, including cGMP-dependent and -independent pathways, probably affecting carcinogenetic processes beyond GCCregulated invasive cell shape, a model currently being explored in this laboratory.
Present findings also support the existence of a biological divergence between cGMP and cAMP signaling on Ena/VASP activities, an established paradigm in neurons where the cAMP-VASP axis mediates attractive guidance cues by increasing the number and length of filopodia, while the cGMP/PKG/VASP pathway promotes repulsive guidance cues. [30] [31] However, the precise consequences of cyclic nucleotide signaling through VASP on the actin cytoskeleton appear to be cell and tissue specific, as demonstrated by identical cGMP and cAMP inhibitory actions on platelet aggregation, reflecting respective VASP phosphorylation mechanisms. 32 Regardless, VASP Ser239 phosphorylation induced by cGMP is emerging as a pivotal mechanism mediating VASP redistribution and disassembly of VASP-regulated membrane protrusions, including filopodia and lamellipodia.
14, [33] [34] In that context, Ser239 is strategically located within the EVH2 domain of VASP, immediately adjacent to the G-actin binding site, which localizes VASP at filopodial tips and coordinates the transfer of profilin-bound G-actin to the barbed end of the elongating F-actin filament. 33 Phosphorylation of VASP Ser239 interferes with EVH2-dependent processes at membrane leading edges, destabilizing VASP-actin interactions and organelle protrusive dynamics. 14, 33 Moreover, VASP Ser239, but not VASP Ser157, phosphorylation inhibits VASP-driven F-actin polymerization. 13 This study demonstrates VASP Ser239 phosphorylation suppresses the invasive actin cytoskeleton of tumor cells and represents an unappreciated prototype to be exploited in innovative diagnostic and therapeutic approaches for colorectal cancer.
Specifically, ligand-dependent GCC signaling may prevent colon cancer metastasis by neutralizing oncogenic VASP functions at the invasive cancer front.
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